- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2C
- Website
- myhelaina.com
- Total Funding
- $69.4M
- Last Round
- $45.0M Series BSep 2024
- Rounds
- 3
About
Biotech company producing human-equivalent bioactive proteins (effera™) via precision fermentation for nutrition brands and infant formula.
Summary
Helaina is a Biotech company based in New York, United States, founded in 2019. It has raised $69.4M in total across 3 rounds, most recently a $45.0M Series B round in Sep 2024. Investors include Spark Capital, Primary VC and Avidity Partners.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...
A pioneer in the cell-based meat industry.
Meituan is one of the largest local services e-commerce marketplaces in China.
Community-based grocery retail platform
Southeast Asia's leading on-demand super app offering ride-hailing, food delivery, payments, and ...